Cargando…
Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretion
BACKGROUND: Cerebral ischemia is associated with the activation of glial cells, infiltration of leukocytes and an increase in inflammatory mediators in the ischemic brain and systemic circulation. How this inflammatory response influences lesion size and neurological outcome remains unclear. D-JNKI1...
Autores principales: | Benakis, Corinne, Vaslin, Anne, Pasquali, Christian, Hirt, Lorenz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416579/ https://www.ncbi.nlm.nih.gov/pubmed/22533966 http://dx.doi.org/10.1186/1742-2094-9-76 |
Ejemplares similares
-
Therapeutic Administration of the Chemokine CXCL1/KC Abrogates Autoimmune Inflammatory Heart Disease
por: Bachmaier, Kurt, et al.
Publicado: (2014) -
Correction: Therapeutic Administration of the Chemokine CXCL1/KC Abrogates Autoimmune Inflammatory Heart Disease
Publicado: (2014) -
Effects of interleukin-10 on chemokine KC gene expression by mouse peritoneal macrophages in response to Candida albicans.
por: Kim, H. S., et al.
Publicado: (1999) -
Atenolol Reduces Leishmania major-Induced Hyperalgesia and TNF-α Without Affecting IL-1β or Keratinocyte Derived Chemokines (KC)
por: Karam, Marc C., et al.
Publicado: (2016) -
C-Terminal Engineering of CXCL12 and CCL5 Chemokines: Functional Characterization by Electrophysiological Recordings
por: Picciocchi, Antoine, et al.
Publicado: (2014)